MARGIN CALLS AT ITALY'S A2A HAVE HALVED FROM A PEAK OF MORE THAN…
MARGIN CALLS AT ITALY'S A2A HAVE HALVED FROM A PEAK OF MORE THAN 1.5 BLN EUROS IN AUGUST - A2A CEO ...
Soleno Therapeutics, Inc. announced it will receive $59.89 Million in funding from Abingworth LLP, Vivo Capital, LLC, Nantahala Capital Management, LLC, Brightleaf Capital, Corbin Capital Partners, L.P.